DrugPatentWatch Database Preview
Drugs in Development Information for Vonoprazan
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug Vonoprazan?
Vonoprazan is an investigational drug.
There have been 15 clinical trials for Vonoprazan.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 21st 2017.
The most common disease conditions in clinical trials are Esophagitis, Helicobacter Infections, and Gastroesophageal Reflux. The leading clinical trial sponsors are Takeda, Phathom Pharmaceuticals, Inc., and Hamamatsu University.
There are seventeen US patents protecting this investigational drug and one hundred and fifty-four international patents.
Summary for Vonoprazan
| US Patents | 17 |
| International Patents | 154 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2017-04-21) |
| Vendors | 28 |
Recent Clinical Trials for Vonoprazan
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection | Takeda | Phase 3 |
| Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection | Phathom Pharmaceuticals, Inc. | Phase 3 |
| Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis | Phathom Pharmaceuticals, Inc. | Phase 3 |
Clinical Trial Summary for Vonoprazan
Top disease conditions for Vonoprazan
Top clinical trial sponsors for Vonoprazan
US Patents for Vonoprazan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vonoprazan | Start Trial | 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same | Takeda Pharmaceutical Company Limited (Osaka-Shi, JP) | Start Trial |
| Vonoprazan | Start Trial | Proton pump inhibitors | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Vonoprazan | Start Trial | Method for producing sulfonyl chloride compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | Start Trial |
| Vonoprazan | Start Trial | Acid secretion inhibitor | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vonoprazan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vonoprazan | China | 102421753 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 104211618 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 105524046 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 108129374 | 2029-02-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
